Jodie Wehling

Jodie Wehling is Vice President and Head of Market Access, Trade & Distribution, and Contracting at Mesoblast. She is a global and U.S. market access executive focused on optimizing patient access to innovative therapies, including cell and gene therapies, oncology, rare disease, immunology, multiple sclerosis, and cardiovascular treatments. Jodie is recognized for launch excellence and strategic leadership, having supported the launch of nine therapies in the past seven years. She builds and leads high-performing teams across market access, managed markets, marketing, and sales while developing value-driven strategies spanning pricing, payer engagement, patient services, policy, and distribution to ensure sustainable access to transformative therapies.